Biodegradable Medical Polymers Market Report 2026

Biodegradable Medical Polymers Market Overview

• Biodegradable Medical Polymers market size has reached to $2.78 billion in 2025 • Expected to grow to $5.95 billion in 2030 at a compound annual growth rate (CAGR) of 16.4% • Growth Driver: Growth In Minimally Invasive Surgeries Boosts Market Due To Their Ability to Enhance Recovery, Reduce Secondary Procedures, And Improve Surgical Efficiency • Market Trend: Adoption of Biopolymer Technologies Enhances Sustainability And Performance In Biodegradable Medical Polymers • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biodegradable Medical Polymers Market?

Biodegradable medical polymers refer to a class of innovative materials that can decompose into harmless byproducts within the body or environment after completing their medical purpose. They help reduce postoperative complications, support natural healing, and eliminate the need for removal procedures. Their excellent biocompatibility and controlled degradation make them key components in advancing modern medical treatments. The main product types of biodegradable medical polymers are polylactic acid, polyglycolic acid, polycaprolactone, polyhydroxyalkanoates, others. Polylactic acid is a biodegradable thermoplastic derived from renewable resources such as corn starch and sugarcane, widely used in medical and packaging applications. The various material types include ceramic matrix composites (CMC), oxide ceramics, non-oxide ceramics, advanced porous ceramics. The various product forms include powder, tiles, coatings, fibres, bulk. These are used in various applications such as drug delivery, implants, sutures, others.

What Is The Biodegradable Medical Polymers Market Growth Forecast?

The biodegradable medical polymers market size is expected to see rapid growth in the next few years. It will grow to $5.95 billion in 2030 at a compound annual growth rate (CAGR) of 16.4%. The growth in the forecast period can be attributed to increasing demand for minimally invasive procedures, rising focus on sustainable medical materials, expansion of drug-device combination products, growing investments in regenerative medicine, advancements in precision polymer engineering. Major trends in the forecast period include increasing use of bioabsorbable implant materials, rising demand for controlled degradation polymers, growing adoption of polymers in drug delivery systems, expansion of advanced biopolymer processing techniques, enhanced focus on biocompatibility and safety.

What Is The Driver Of The Biodegradable Medical Polymers Market?

The increasing demand for minimally invasive procedures is expected to propel the growth of the biodegradable medical polymers market going forward. Minimally invasive procedures are medical techniques that use small incisions or non-invasive methods to perform surgeries or interventions with reduced tissue damage, faster recovery times, and less postoperative pain compared to traditional surgical methods. Minimally invasive procedures are increasing due to advancements in medical technology, resulting in a higher adoption of precision-driven surgical techniques worldwide. Biodegradable medical polymers support minimally invasive surgeries by enabling the development of temporary implants, sutures, and drug delivery systems that naturally dissolve within the body, reducing the need for secondary removal procedures, minimizing tissue trauma, and promoting faster patient recovery with fewer complications. For instance, in February 2023, according to the American Society of Plastic Surgeons, a US-based specialty organization, the total number of cosmetic minimally invasive procedures increased from 23.7 million in 2022 to 25.4 million in 2023. Therefore, the increasing demand for minimally invasive procedures is driving the growth of the biodegradable medical polymers industry.

Key Players In The Global Biodegradable Medical Polymers Market

Major companies operating in the biodegradable medical polymers market are Evonik Industries AG, Corbion N.V., dsm-firmenich AG, Mitsui Chemicals Inc., Poly Medicure Limited, KLS Martin SE & Co. KG, BASF SE, NatureWorks LLC, Arkema SA, Eastman Chemical Company, Foster LLC, Becton Dickinson and Company, Toray Industries Inc., Celanese Corporation, Teysa Technologies Ltd, Kaneka Corporation, Arthrex Inc., Ashland Inc., Meril Life Sciences India Private Limited, Reva Medical LLC

Global Biodegradable Medical Polymers Market Trends and Insights

Major companies operating in the biodegradable medical polymers market are focusing on innovative technologies such as biopolymer technology to enhance the performance, biocompatibility, and sustainability of medical devices and drug delivery systems. Biopolymer technology refers to the science and application of polymers derived from natural sources designed to be biodegradable and environmentally friendly and is used to create sustainable materials for medical, packaging, and industrial applications while reducing reliance on synthetic plastics. For instance, in November 2023, Sulzer Ltd., a Switzerland-based Swiss public company, introduced CAPSUL, a new end-to-end licensed technology for the continuous manufacturing of polycaprolactone (PCL), a biodegradable polyester, enabling the production of high-quality PCL grades at competitive rates. This launch aims to promote the use of sustainable and biodegradable materials, improve production efficiency, and provide high-quality eco-friendly polymers for medical and industrial applications.

What Are Latest Mergers And Acquisitions In The Biodegradable Medical Polymers Market?

In July 2023, Evonik Industries AG, a Germany-based chemicals company, acquired Novachem Corporation for an undisclosed amount. Through this acquisition, Evonik Industries AG aims to enhance its sustainable cosmetic active ingredients portfolio by integrating Novachem Corporation's innovative, biotechnological, and eco-certified actives while strengthening its System Solutions offering in the personal care market across the Americas and supporting its transformation into sustainable specialties. Novachem Corporation is a Canada-based petrochemical company that manufactures biodegradable medical polymers.

What Defines the Biodegradable Medical Polymers Market?

The biodegradable medical polymers market consists of sales of sutures, drug delivery systems, wound dressings, orthopedic devices, dental implants, tissue engineering scaffolds, and surgical instruments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Biodegradable Medical Polymers Market Report 2026?

The biodegradable medical polymers market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biodegradable medical polymers industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.